The interaction of miR-181a-5p and sirtuin 1 regulated human bone marrow mesenchymal stem cells differentiation and...

Area of Science:

• Biochemistry
• Molecular Biology
• Cell Biology

Background:

• Osteoporosis (OP) involves decreased bone density, leading to fractures.
• MicroRNAs (miRNAs) play a critical role in bone-related diseases.
• Understanding miRNA involvement in bone metabolism is vital for OP research.

Purpose of the Study:

• To investigate the role of miR-181a-5p in human bone marrow mesenchymal stem cells (hBMSCs).
• To elucidate the regulatory mechanisms of miR-181a-5p in hBMSC viability, differentiation, and apoptosis.
• To identify the downstream targets and signaling pathways affected by miR-181a-5p.

Main Methods:

• Overexpression and inhibition of miR-181a-5p in hBMSCs.
• Cell viability assays, apoptosis assays, and alkaline phosphatase (ALP) activity measurements.
• Quantitative real-time PCR and Western blotting for gene and protein expression analysis.
• Luciferase reporter assay to confirm target genes.
• Manipulation of Sirtuin 1 (Sirt1) and PI3K/AKT pathway components.

Main Results:

• miR-181a-5p overexpression reduced hBMSC viability and proliferation.
• Apoptosis of hBMSCs increased with miR-181a-5p overexpression and decreased with inhibition.
• miR-181a-5p significantly inhibited differentiation markers (ALP, OPN, Runx2, OCN).
• Sirt1 was identified as a direct target of miR-181a-5p.
• Sirt1 modulated the effects of miR-181a-5p on apoptosis and differentiation via the PI3K/AKT pathway.

Conclusions:

• miR-181a-5p acts as a negative regulator of hBMSC differentiation and viability.
• miR-181a-5p promotes hBMSC apoptosis.
• The miR-181a-5p/Sirt1/PI3K/AKT axis is a key pathway in regulating hBMSC fate.
• This pathway represents a potential therapeutic target for osteoporosis.